Psoriatic arthritis (PsA) is a chronic inflammatory joint disease with heterogeneous clinical presentation, an unpredictable course and a tendency to irreversible joint damage. Joint damage can occur early in the disease also when significant clinical signs of arthritis are absent. These observations and currently availabe effective treatments in controlling skin and joint disease underline the importance of early diagnosis of psoriatic arthritis. Use of specific questionnaires for screening at-risk patients, knowledge of new classification criteria and judicious use of new imaging techniques are key to early diagnosis. Besides traditional terapy with non-steroidal anti-inflammatory drugs and the more active disease-modifying anti-rheumatic drugs, the advent of biologics (anti-tumor necrosis factor- inhibitors) has considrerably enhanced treatment options. Collaboration between dermatologists, radiologists and rheumatologists offers a new opportunity to establish early diagnosis and effective therapy for psoriatic arthritis.

Diagnosis and management of psoriatic arthritis / G. Altomare, F. Capsoni. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 1827-1820. - 149:suppl. 2(2014 Feb), pp. 1-5.

Diagnosis and management of psoriatic arthritis

G. Altomare
Primo
;
F. Capsoni
Ultimo
2014

Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory joint disease with heterogeneous clinical presentation, an unpredictable course and a tendency to irreversible joint damage. Joint damage can occur early in the disease also when significant clinical signs of arthritis are absent. These observations and currently availabe effective treatments in controlling skin and joint disease underline the importance of early diagnosis of psoriatic arthritis. Use of specific questionnaires for screening at-risk patients, knowledge of new classification criteria and judicious use of new imaging techniques are key to early diagnosis. Besides traditional terapy with non-steroidal anti-inflammatory drugs and the more active disease-modifying anti-rheumatic drugs, the advent of biologics (anti-tumor necrosis factor- inhibitors) has considrerably enhanced treatment options. Collaboration between dermatologists, radiologists and rheumatologists offers a new opportunity to establish early diagnosis and effective therapy for psoriatic arthritis.
arthririts; psoriasis; diagnosis
Settore MED/16 - Reumatologia
Settore MED/35 - Malattie Cutanee e Veneree
feb-2014
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/261652
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact